AMAGINE Archives - Medical Conferences

Brodalumab onset of action is significantly faster than ustekinumab: Results from the phase 3 AMAGINE-2 and -3 studies

Presented By

Dr Sandra Philipp, Charité-Universitätsmedizin Berlin, Germany

Trial

Phase 3, AMAGINE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 21:59

Sustained and complete responses from the phase 3 AMAGINE-2 and -3 studies

Presented By

Prof. Lluís Puig, Hospital de la Santa Creu i Sant Pau, Spain

Trial

Phase 3, AMAGINE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 15:29

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com